Patient data capture and clinical trial tech company uMotif announced Wednesday it had secured $25.5 million from a fund managed by Athyrium Capital Management.
The London-based firm raised £5 million in a Series A funding in 2020 and £2.4 million in 2018.
WHAT IT DOEs
uMotif makes software for gathering patient data for clinical trials and research, including decentralized studies. Its offerings...
UK-based data capture software company, uMotif, has raised £5 million in a Series A investment round led by existing investor AlbionVC.
The funding will accelerate uMotif’s growth and enable further development of its patient-centric and decentralised approach to clinical studies and enable expansion into new study types and more high-demand territories.
WHY IT MATTERS
Life sciences companies...
Patient-facing clinical trial software company uMotif has raised $3.2 million (£2.4 million) in a new funding round led by independent investment manager Albion Capital, with additional participation from unnamed angel investors.
uMotif makes apps for capturing consent, electronic patient-reported outcomes (ePRO), and electronic clinical outcome assessment (eCOA). The UK-based company, founded in...
People with Parkinson’s disease who used an app to track and manage symptom improved their medication adherence and had better conversations with clinicians about their condition, according to the results of a recent National Health Services study published in the journal Nature Parkinson’s.
Representing the largest randomized controlled trial of a digital technology for Parkinson’s Disease,...
Researchers from the University of Manchester have launched an app-based study, called Cloudy with a Chance of Pain, that will study the relationship between the weather and chronic pain in the UK.
The initiative was launched in partnership with Arthritis Research UK, health app company uMotif, New York-based Office for Creative Research, and the University’s Health e-Research Centre.
Users aged...
